2-O-b-D-Xylopyranosyl-L-arabinose

Metabolite details

Identifier

HBIRURHHLFDSPS-BIDIDBDVSA-N

InChI Key

HBIRURHHLFDSPS-BIDIDBDVSA-N

IUPAC name

(3R,4S,5S)-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxane-2,4,5-triol

Preferred name

2-O-b-D-Xylopyranosyl-L-arabinose

INN name

—

Synonym

—

ChEBI

CHEBI:174693

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Transcriptional memory of dFOXO activation in youth curtails later-life mortality
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• RU-_Control_vs_RU+_Switch
• G1_PBS_vs_G2_DSS
• Control_vs_ZYP_High_Dose